Le Lézard
Classified in: Health, Science and technology, Business
Subjects: SVY, PLW

Innovation in Healthcare and Digital Technologies Boosts European Patent Applications by U.S. Companies


MUNICH, March 19, 2024 /PRNewswire/ -- U.S. companies filed 48 155 patent applications at the European Patent Office last year, an increase of 0.4% compared to 2022, according to the EPO's Patent Index 2023. The U.S. thus accounted for 24.2% of the total patent applications received by the EPO in 2023. The U.S. consistently ranks as the top filing country at the EPO, and the number of patent applications has increased by +31.3% since 2014. 

"Our latest Patent Index shows that innovation remained vibrant around the world in 2023," said?EPO President?António Campinos. "The EPO was entrusted with examining more applications than ever before, attesting to both the attractiveness of the European technology market and the high quality of our products and services. Europe's small and medium-sized enterprises are making ever-increasing use of patents, with the share of applications from SMEs at its highest level yet last year. These businesses can also now benefit from the new Unitary Patent, which significantly improves the environment for innovation in Europe, providing a simpler and more cost-effective option for innovators to protect their inventions and bring them to the vast EU market." 

The U.S. growth was driven by increased patent applications in healthcare and digital technologies, making up the five leading U.S technology fields with the most patent applications in Europe: medical technology (6 098 patent applications), computer technology (5 111), digital communication (5 008), pharmaceuticals (3 802), biotechnology (2 751).

Qualcomm was the top applicant at the EPO in 2023 in digital communication and measurement, while RTX Corporation ranked 1st at the EPO in transport. U.S. firms led in the medical technology field at the EPO, with Medtronic in the top spot, Johnson & Johnson 3rd, Becton, Dickinson and Company 4th and Boston Scientific Corporation 5th.

California was the leading region in the world for European patent applications, ahead of Tokyo (Japan). The state with the second highest number of applications was Massachusetts, followed by New York, and Texas.

Since 1 June 2023, innovators seeking patent protection across Europe can also benefit from the Unitary Patent ? a new way to obtain simpler and cheaper patent protection in at present 17 EU member states, in which a European patent can be requested to have unitary legal effect and be enforced or litigated before the new Unified Patent Court. The Unitary Patent system has already proven popular with patent owners: unitary protection was requested for 17.5% of all European patents granted in 2023 (more than 18 300 requests filed) and for 22.3% of those granted in the second half of 2023. Patentees from the 39 EPO member states had the highest uptake rate at 25.8% of the patents granted, followed by those from the U.S. and China (both 10.9%), Republic of Korea (9.7%) and Japan (4.9%). The top Unitary Patent requestors in 2023 were Johnson & Johnson, Siemens, Qualcomm, Samsung and Ericsson.

Photo - https://mma.prnewswire.com/media/2365199/US_top_applicants_2023.jpg

SOURCE European Patent Office


These press releases may also interest you

at 03:05
In Q1 2024, LEO Pharma delivered a revenue growth of 13% in constant exchange rates (CER). The dermatology portfolio saw accelerated growth in revenue of 16%. The acquisition of TMB-001 to the treatment of congenital ichthyosis added a late-stage...

at 02:22
Hansa Biopharma AB (publ), ("Hansa" or the "Company") (STO: HNSA) today announced that the company's registered share capital and number of shares and votes have increased through the issue of 10,474,740 new ordinary shares on 12 April 2024, whereby...

at 02:20
Vicore Pharma Holding (STO:VICO) Stockholm, May 3 2024- Vicore Pharma Holding AB (STO:VICO) ("Vicore"), unlocking the potential of a new class of drug candidates, angiotensin II type 2 receptor agonists (ATRAGs), publishes the interim...

2 mai 2024
The report titled "Muscle Stimulator Market by Technique (Burst Mode Alternating Current, Functional Electrical Stimulation, Interferential), Modality (Handheld, Portable, Table Top), Area, Application, End-User - Global Forecast 2024-2030" is now...

2 mai 2024
Epredia, a global leader in precision cancer diagnostics and subsidiary of PHC Holdings Corporation (TSE: 6523), and NovaScan, Inc., a company that develops breakthrough technology for cancer detection and stratification, announce that they have...

2 mai 2024
The United States of America and ReNew Health Group LLC have settled a nursing home whistleblower claim involving allegations that the nursing home chain submitted false Medicare claims. We need transparency and accountability in our nursing homes....



News published on and distributed by: